{"id":202507,"date":"2024-12-27T02:02:25","date_gmt":"2024-12-27T08:02:25","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/12\/using-ai-to-repurpose-existing-drugs-for-treatment-of-rare-diseases"},"modified":"2024-12-27T02:02:25","modified_gmt":"2024-12-27T08:02:25","slug":"using-ai-to-repurpose-existing-drugs-for-treatment-of-rare-diseases","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/12\/using-ai-to-repurpose-existing-drugs-for-treatment-of-rare-diseases","title":{"rendered":"Using AI to repurpose existing drugs for treatment of rare diseases"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/using-ai-to-repurpose-existing-drugs-for-treatment-of-rare-diseases2.jpg\"><\/a><\/p>\n<p>Although each condition occurs in a small number of individuals, collectively these diseases exert a staggering human and economic toll because they affect some 300 million people worldwide. Yet, with a mere 5 to 7 percent of these conditions having an FDA-approved drug, they remain largely untreated or undertreated.<\/p>\n<p>Developing new medicines represents a daunting challenge, but a new artificial intelligence tool can propel the discovery of new therapies from existing medicines, offering hope for patients with rare and neglected conditions and for the clinicians who treat them.<\/p>\n<p>The AI model, called TxGNN, is the first one developed specifically to identify drug candidates for rare diseases and conditions with no treatments.<\/p>\n<hr>\n<p>Identifies possible therapies for thousands of diseases, including ones with no current treatments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Although each condition occurs in a small number of individuals, collectively these diseases exert a staggering human and economic toll because they affect some 300 million people worldwide. Yet, with a mere 5 to 7 percent of these conditions having an FDA-approved drug, they remain largely untreated or undertreated. Developing new medicines represents a daunting [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,39,6],"tags":[],"class_list":["post-202507","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-economics","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/202507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=202507"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/202507\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=202507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=202507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=202507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}